Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Net Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$4.41B
↑ 40% above average
Average (9y)
$3.16B
Historical baseline
Range
High:$8.08B
Low:$636.06M
CAGR
+24.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $4.41B | +11.6% |
| 2023 | $3.95B | -8.9% |
| 2022 | $4.34B | -46.3% |
| 2021 | $8.08B | +129.9% |
| 2020 | $3.51B | +66.0% |
| 2019 | $2.12B | -13.4% |
| 2018 | $2.44B | +104.0% |
| 2017 | $1.20B | +33.8% |
| 2016 | $895.52M | +40.8% |
| 2015 | $636.06M | - |